These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8849537)

  • 21. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
    Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas.
    Ye HQ; Maeda M; Yu FS; Azar DT
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2894-9. PubMed ID: 10967042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
    Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
    Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant tissue inhibitor of metalloproteinases type 1 suppresses alkali-burn-induced corneal ulceration in rabbits.
    Paterson CA; Wells JG; Koklitis PA; Higgs GA; Docherty AJ
    Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):677-84. PubMed ID: 8113019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis.
    Rohini G; Murugeswari P; Prajna NV; Lalitha P; Muthukkaruppan V
    Cornea; 2007 Feb; 26(2):207-11. PubMed ID: 17251814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of lipid peroxide on production of matrix metalloproteinase 1 (tissue collagenase) and 3 (stromelysin) and tissue inhibitor metalloproteinase 1 by human rheumatoid synovial fibroblasts.
    Hiraoka K; Sasaguri Y; Komiya S; Zenmyo M; Inoue A; Morimatsu M
    Exp Mol Pathol; 1993 Dec; 59(3):169-76. PubMed ID: 8137899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis.
    Chabaud M; Garnero P; Dayer JM; Guerne PA; Fossiez F; Miossec P
    Cytokine; 2000 Jul; 12(7):1092-9. PubMed ID: 10880256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis.
    Iredale JP; Benyon RC; Arthur MJ; Ferris WF; Alcolado R; Winwood PJ; Clark N; Murphy G
    Hepatology; 1996 Jul; 24(1):176-84. PubMed ID: 8707259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis.
    Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
    J Rheumatol; 2004 Feb; 31(2):238-42. PubMed ID: 14760791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.
    Kernacki KA; Barrett R; Hazlett LD
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
    Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
    Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
    Ikema K; Matsumoto K; Inomata Y; Komohara Y; Miyajima S; Takeya M; Tanihara H
    Exp Eye Res; 2006 Dec; 83(6):1396-404. PubMed ID: 16968651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury.
    Fini ME; Parks WC; Rinehart WB; Girard MT; Matsubara M; Cook JR; West-Mays JA; Sadow PM; Burgeson RE; Jeffrey JJ; Raizman MB; Krueger RR; Zieske JD
    Am J Pathol; 1996 Oct; 149(4):1287-302. PubMed ID: 8863676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levels of circulating collagenase, stromelysin-1, and tissue inhibitor of matrix metalloproteinases 1 in patients with rheumatoid arthritis. Relationship to serum levels of antigenic keratan sulfate and systemic parameters of inflammation.
    Manicourt DH; Fujimoto N; Obata K; Thonar EJ
    Arthritis Rheum; 1995 Aug; 38(8):1031-9. PubMed ID: 7639798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of corneal fibroblast MMP-1 collagenase secretion by plasmin.
    Berman MB
    Cornea; 1993 Sep; 12(5):420-32. PubMed ID: 8306664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of collagenase and cell types in sterile ulceration of human corneal grafts.
    Wagoner MD; Kenyon KR
    Acta Ophthalmol Suppl (1985); 1989; 192():65-71. PubMed ID: 2554659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis.
    Clark IM; Powell LK; Ramsey S; Hazleman BL; Cawston TE
    Arthritis Rheum; 1993 Mar; 36(3):372-9. PubMed ID: 8452582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The levels of collagenase, tissue inhibitor of metalloproteinases-1 (TIMP-1), collagenase approximately TIMP-1 complexes and glycosaminoglycan (GAG) in sequential samples of synovial fluid aspirated from patients with osteoarthritis.
    Cawston TE; Curry V; Ramsey S; Clark IM; Kyle VA; Adebajo A; Silverman B; Daymond T; Hazleman BL
    Clin Exp Rheumatol; 1995; 13(4):431-7. PubMed ID: 7586773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agonist-induced expression of tissue inhibitor of metalloproteinases and metalloproteinases by human macrophages is regulated by endogenous prostaglandin E2 synthesis.
    Pentland AP; Shapiro SD; Welgus HG
    J Invest Dermatol; 1995 Jan; 104(1):52-7. PubMed ID: 7798641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use.
    O'Brien TP; Li QJ; Sauerburger F; Reviglio VE; Rana T; Ashraf MF
    Ophthalmology; 2001 Apr; 108(4):656-9. PubMed ID: 11297478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.